Daniel Friedman

Daniel Friedman

Directeur/Membre du Conseil chez PBS Biotech, Inc.

Finance
Consumer Services
Commercial Services

Profil

Daniel Friedman is a Vice President on BroadOak’s growth capital investing team where he specializes in portfolio management and investment execution.
Prior to joining BroadOak in 2019, Daniel worked for Raymond James within the Life Sciences Investment Banking team where he focused on public financings and M&A for biotechnology and medical device companies.
Daniel currently serves as Secretary of the Board of Biolog as well as Board Observer at PBS Biotech.
Daniel previously acted as a board observer at both Avidien Technologies and antibodies-online.
Daniel earned a B.B.A.
with concentrations in finance and accounting from the Ross School of Business at the University of Michigan.

Postes actifs de Daniel Friedman

SociétésPosteDébut
Private Equity Investor 01/01/2022
Directeur/Membre du Conseil 01/09/2023
Tous les postes actifs de Daniel Friedman

Formation de Daniel Friedman

Stephen M. Ross School of Business Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Daniel Friedman

Relations

100 +

Relations au 1er degré

3

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées2

Finance

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Daniel Friedman